WIReDSpace
metadata only
Serum levels of transforming growth factor Beta 1 in Systemic Lupus Erythematosus patients
Transforming growth factor beta (TGF-β) is a highly pleiotropic cytokine that has broad anti-inflammatory and immunosuppressive effects. In patients with systemic lupus erythematosus (SLE), the immunosuppressive effect of TGF-β1 is thought to be dysfunctional. In the present work, we aimed to study
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- IL17 in Systemic Lupus Erythematosus Patients: Association With Disease Activity and Organ Damage#1029802
- Evaluation Of Serum MIF Level in SLE Patients#858465
- Bioinformatics analysis identifies biomarkers associated with T-cell depletion in systemic lupus erythematosus.#251052
- Discontinuation or Continuation of Immunosuppressive Therapy in Participants With Chronic Graft Versus Host Disease#121366
- IFN-α and CD46 stimulation are associated with active lupus and skew natural T regulatory cell differentiation to type 1 regulatory T (Tr1) cells#1251477
Record · ID 1361085
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive